Company intelligence / Profile preview

TiterMax USA

Norcross, Georgia, United States

Ownership: Private
Development stage: Other

Overview

TiterMax USA manufactures immunological adjuvants for research use, primarily formulated to induce cell-mediated and humoral immune responses in laboratory animals. Their flagship product, TiterMax Classic, is a potent, non-toxic alternative to Freund’s Complete Adjuvant and is not itself a therapeutic or clinical-stage asset but an ancillary reagent for biomedical research[1][2][3][6][7][9].

Modalities: Adjuvant (immunological adjuvant)Water-in-oil emulsion
Industry: Non-Drug Biotech

Partnerships

Sigma-Aldrich (distributor)[7][9]HiSS Diagnostics (distributor)[2]Funakoshi (Japan distributor)[8]CedarLane Laboratories (Canada distributor)[8]Stratech Scientific (UK distributor)[8]Advanced Biotechnology Laboratories (Taiwan distributor)[8]

Beyond the preview

Go deeper on TiterMax USA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TiterMax USA.

Explore the full profile